Pictet & Cie (Europe) Sa Guardant Health, Inc. Transaction History

Pictet & Cie (Europe) Sa

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 05, 2022	SELL	$28.82 - $77.35 $47,870 - $128,478	-1,661 Reduced 19.67%	6,784 $274,000
Q1 2022 May 04, 2022	BUY	$48.25 - $100.49 $78,406 - $163,296	1,625 Added 23.83%	8,445 $559,000
Q4 2021 Feb 02, 2022	SELL	$88.71 - $120.43 $101,750 - $138,133	-1,147 Reduced 14.4%	6,820 $682,000
Q3 2021 Nov 10, 2021	BUY	$98.77 - $132.17 $33,483 - $44,805	339 Added 4.44%	7,967 $996,000
Q2 2021 Aug 11, 2021	BUY	$109.77 - $165.68 $213,063 - $321,584	1,941 Added 34.13%	7,628 $947,000
Q1 2021 May 10, 2021	BUY	$127.04 - $179.1 $722,476 - $1.02 Million	5,687 New	5,687 $868,000

323

127M

844K

2.38M

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $3.75B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

Get notified when there are updates to the investment portfolio of Pictet & Cie (Europe) Sa, based on Form 13F filings with the SEC.

Stay updated on Pictet & Cie (Europe) Sa with notifications on news.